Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

Healthstream (HSTM) Long-Term Debt Repayments (2010 - 2011)

Healthstream (HSTM) reported Long-Term Debt Repayments of $1000.0 for Q4 2011, down 99.68% year-over-year from $309000.0 in Q4 2010, and down 50.0% on a QoQ basis from $2000.0 in Q3 2011.

Healthstream (HSTM) has 2 years of Long-Term Debt Repayments data on file, last reported at $1000.0 in Q4 2011.

  • Quarterly Long-Term Debt Repayments fell 99.68% year-over-year to $1000.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $5000.0 (changed N/A YoY) and the FY2011 annual result came in at $5000.0, down 98.42% from the prior year.
  • Long-Term Debt Repayments fell to $1000.0 in Q4 2011 per HSTM's latest filing, from $2000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $309000.0 in Q4 2010 and bottomed at -$299942.0 in Q3 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 12.35 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 15.00 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 23.55 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Healthstream 752.32 Mn 685.82 Mn 68.24 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 1,000.00
Dec 31, 2011 1,000.00
Sep 30, 2011 2,000.00
Sep 30, 2011 2,000.00
Mar 31, 2011 2,000.00
Mar 31, 2011 2,000.00
Dec 31, 2010 309,000.00
Dec 31, 2010 309,000.00
Sep 30, 2010 -299,942.00
Sep 30, 2010 -299,942.00